Literature DB >> 25803732

Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis.

.   

Abstract

[In the article "Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis" which appeared in Volume 93, Issue 28 of Medicine, Abd Elrazek Abd Elrazek's name incorrectly appeared as Abd Elrazek M. Aly Abd Elrazek.].

Year:  2015        PMID: 25803732      PMCID: PMC4602556          DOI: 10.1097/01.md.0000460806.85095.df

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


In the article “Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt: A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis”[1] which appeared in Volume 93, Issue 28 of Medicine, Abd Elrazek Abd Elrazek's name incorrectly appeared as Abd Elrazek M. Aly Abd Elrazek. The article has since been corrected and reposted online.
  1 in total

1.  Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.

Authors:  Abd Elrazek Abd Elrazek; Shymaa E Bilasy; Abduh E M Elbanna; Abd Elhalim A Elsherif
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.